Comprehensive Investigation of the Tki Resistance Mechanisms in Advanced Lung Cancer by Multi-Omics and Single Cell Sequencing Analyses to Develop New Strategy for Tki-Resistant Patients( I )=藉多體學與單細胞定序針對晚期肺癌標靶藥物抗藥性機制的完整研究以研發治療標靶藥物抗藥之新策略(1/3)

Project title

藉多體學與單細胞定序針對晚期肺癌標靶藥物抗藥性機制的完整研究以研發治療標靶藥物抗藥之新策略(1/3)

Internal ID

110-2327-B-002-008

Principal Investigator

Start Date

August 1, 2021

End Date

July 31, 2022

Organizations

Partner Organizations

National Science and Technology Council